CHIP has also been linked to chronic inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), as well as infections with significant CVD burden, like coronavirus disease 2019 (COVID-19) and human immunodeficiency virus (HIV), where altered innate and adaptive immune responses may further reinforce systemic cytokine dysregulation [31]. This evidence concerns the gene STUB1 and COVID-19.